EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $198 | +1.0% | 12,566 | +24.8% | 0.02% | +9.1% |
| Q2 2023 | $196 | -2.0% | 10,066 | +42.5% | 0.02% | -8.3% |
| Q1 2023 | $200 | -99.9% | 7,066 | 0.0% | 0.02% | -7.7% |
| Q4 2022 | $206,539 | -23.5% | 7,066 | +16.5% | 0.03% | -23.5% |
| Q2 2022 | $270,000 | -16.9% | 6,066 | -7.6% | 0.03% | 0.0% |
| Q1 2022 | $325,000 | -2.7% | 6,566 | 0.0% | 0.03% | +3.0% |
| Q4 2021 | $334,000 | -8.7% | 6,566 | 0.0% | 0.03% | -15.4% |
| Q3 2021 | $366,000 | +30.2% | 6,566 | 0.0% | 0.04% | +34.5% |
| Q2 2021 | $281,000 | +51.9% | 6,566 | +65.6% | 0.03% | +26.1% |
| Q4 2020 | $185,000 | – | 3,966 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |